Lam Research makes the etch and deposition tools that cut and layer the transistor structures inside advanced logic and memory chips, and it sells a large share of its revenue into wafer fab expansion at TSMC, Samsung and the memory makers. Its moat rests on process know-how and installed-base service: once a fab qualifies a Lam etch step, switching tools means requalifying a process that runs on millions of wafers, which keeps share sticky and supports a 50.5% gross margin. The near-term driver is the shift to gate-all-around transistors and higher-layer-count 3D NAND, both of which require more etch and deposition steps per wafer than the previous generation. Revenue growth of 30.0% and a 37.4% operating margin show that this demand is already reaching the income statement rather than sitting in backlog. At 33.7 times forward earnings against 52.3 times trailing, the market is pricing in a sharp step-up in profit that the company has yet to deliver, so the thesis depends on whether the forward numbers hold through the next capex cycle. Worth a deeper look to test that durability against wafer fab equipment spending plans for the next two years.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 23 Oct 2026, 12:04 CEST | Fair value | $156 | $143 | $230 |
| 22 Oct 2026, 01:52 CEST | ACCE price target | $247 | $340 | $261 |
| 21 Oct 2026, 11:06 CEST | Rating | Overvalued | first publication | $263 |
| 21 Oct 2026, 11:06 CEST | Fair value | $143 | $147 | $263 |
| 17 Oct 2026, 00:00 CEST | Fair value | $147 | $151 | $277 |
| 12 Oct 2026, 00:00 CEST | Fair value | $151 | $160 | $319 |
| 3 Oct 2026, 00:00 CEST | ACCE price target | $340 | first publication | $347 |
| 1 Oct 2026, 00:00 CEST | Fair value | $160 | $162 | $324 |
| 24 Sept 2026, 00:00 CEST | Fair value | $162 | $157 | $311 |
| 22 Sept 2026, 00:00 CEST | Fair value | $157 | $161 | $288 |
Answered from Lam Research Corporation Common Stock fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| LRCX Lam Research Corporation Common Stock | $230.10 | $156 | 47% above | 40.0x | 65.1% | 92 | 65 |
| AMAT Applied Materials Inc. Common Stock | $375.58 | $220 | 70% above | 32.5x | 41.1% | 92 | 67 |
| KLAC KLA Corporation Common Stock | $147.83 | $90 | 63% above | 44.7x | 87.5% | 91 | 59 |
| 6857.T Advantest Corporation | ¥32370.00 | - | - | 51.3x | 56.9% | 100 | 77 |
| ASML ASML Holding N.V. New York Registry Shares | $1560.54 | $897 | 74% above | 38.4x | 65.6% | 96 | 75 |
| ASML.AS ASML Holding | €1419.60 | €801 | 77% above | 40.2x | 65.6% | 96 | 77 |
| TER Teradyne Inc. Common Stock | $308.75 | $102 | 202% above | 47.4x | 36.5% | 96 | 67 |
Where LRCX ranks against its sector peers on each metric.